Key Details
Price
$0.95Annual ROE
-34.10%Beta
0.49Events Calendar
Next earnings date:
Mar 20, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Mar 20, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
OXFORD, United Kingdom and GERMANTOWN, Md., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), today announced the promotion of Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer (CSO), effective as of December 1, 2024. Dr. Lynn succeeds Nadège Pelletier, Ph.D. who decided to pursue alternative opportunities closer to home after having served as Barinthus Bio's CSO since early 2023. Barinthus Bio is a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates that guide T cells to control disease.
Eight participants achieved HBsAg loss at any time. Two participants met criteria for functional cure.
Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with
OXFORD, United Kingdom, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), a clinical-stage biopharmaceutical company developing novel immunotherapeutic candidates that guide T cells to control disease, provided an overview of business updates and announced financial results for the third quarter of 2024. “We continue our strong execution on our clinical trials, completing enrollment in the HBV003 trial of VTP-300 in chronic hepatitis B, and advancing VTP-1000 in celiac disease into the clinic with the first in human study of the novel SNAP-TI platform,” said Dr. Leon Hooftman, Chief Medical Officer of Barinthus Bio.
In t he HBV003 trial, 67% of participants had HBsAg
FAQ
- What is the primary business of Barinthus Biotherapeutics?
- What is the ticker symbol for Barinthus Biotherapeutics?
- Does Barinthus Biotherapeutics pay dividends?
- What sector is Barinthus Biotherapeutics in?
- What industry is Barinthus Biotherapeutics in?
- What country is Barinthus Biotherapeutics based in?
- When did Barinthus Biotherapeutics go public?
- Is Barinthus Biotherapeutics in the S&P 500?
- Is Barinthus Biotherapeutics in the NASDAQ 100?
- Is Barinthus Biotherapeutics in the Dow Jones?
- When was Barinthus Biotherapeutics's last earnings report?
- When does Barinthus Biotherapeutics report earnings?
- Should I buy Barinthus Biotherapeutics stock now?